CAS No.607-91-0,Myristicin Suppliers,MSDS download

Products Categories

Pharmaceutical (27)
Plant Extract (24)
Organic Chemicals (13)
Others (10)
Reagent (6)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	607-91-0
Name:	Myristicin

Formula:	C₁₁H₁₂O₃
Molecular Weight:	192.214
Synonyms:	1,3-Benzodioxole,4-methoxy-6-(2-propenyl)- (9CI);Benzene,5-allyl-1-methoxy-2,3-(methylenedioxy)- (7CI,8CI);Myristicin (6CI);5-Allyl-1-methoxy-2,3-(methylenedioxy)benzene;6-Allyl-4-methoxy-1,3-benzodioxole;Myristicine;
EINECS:	210-146-9
Density:	1.137 g/cm³
Melting Point:	<-20oC
Boiling Point:	276.5 °C at 760 mmHg
Flash Point:	89.8 °C
Hazard Symbols:	R52/53:;
Risk Codes:	52/53
Safety:	61
PSA:	27.69000
LogP:	2.15240

Synthetic route

: 75-11-6
diiodomethane

: 4055-72-5
5-Hydroxyeugenol

: 607-91-0
myristicin

Conditions

Conditions	Yield
With potassium carbonate

: 4055-72-5
5-Hydroxyeugenol

: 74-95-3
1,2-dibromomethane

: 607-91-0
myristicin

Conditions

Conditions	Yield
With potassium carbonate
With potassium carbonate In acetone for 20h; Reflux;

: 75-11-6
diiodomethane

: 4055-72-5
5-Hydroxyeugenol

: 67-64-1
acetone

K2CO3: K2CO3

: 607-91-0
myristicin

Conditions

Conditions	Yield
unter Wasserstoff;

...Expand

: 97-53-0
4-allylguaiacol

: 607-91-0
myristicin

Conditions

Conditions	Yield
Multi-step reaction with 3 steps 2: alkaline aqueous H2O2 3: potassium carbonate View Scheme
Multi-step reaction with 3 steps 2: alkaline aqueous H2O2 3: potassium carbonate View Scheme
Multi-step reaction with 3 steps 1: hexan-1-amine / 6 h / Heating 2: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C 3: potassium carbonate / acetone / 20 h / Reflux View Scheme

: 22934-51-6
5-allyl-2-hydroxy-3-methoxybenzaldehyde

: 607-91-0
myristicin

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: alkaline aqueous H2O2 2: potassium carbonate View Scheme
Multi-step reaction with 2 steps 1: alkaline aqueous H2O2 2: potassium carbonate View Scheme
Multi-step reaction with 2 steps 1: dihydrogen peroxide; pyridine; sodium hydroxide / water / 1.5 h / 20 °C 2: potassium carbonate / acetone / 20 h / Reflux View Scheme

: 71186-63-5
2-allyloxy-3-methoxy-phenol

: 607-91-0
myristicin

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme

: 51066-05-8
2-(allyloxy)-6-methoxyphenol

: 607-91-0
myristicin

Conditions

Conditions	Yield
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme
Multi-step reaction with 2 steps 1: 170 - 200 °C / unter Wasserstoff 2: potassium carbonate View Scheme

: 607-91-0
myristicin

: 157426-98-7
2-bromo-1-(3-methoxy-4,5-methylenedioxyphenyl)propane

Conditions

Conditions	Yield
With hydrogen bromide at 20℃;	99.22%

: 607-91-0
myristicin

: 52811-28-6
4-methoxy-6-propyl-benzo[1,3]dioxole

Conditions

Conditions	Yield
With 1% Pd on activated carbon; hydrogen In water at 20℃; under 760.051 Torr; for 12h; Reagent/catalyst; Green chemistry; chemoselective reaction;	99%
With ethanol; palladium Hydrogenation;
With hydrogen In methanol at 20℃; under 15001.5 Torr; for 2h; Autoclave;

: 607-91-0
myristicin

: 14337-43-0
ethyl 2-chloro-2-(hydroxyimino)acetate

: 924859-11-0
ethyl 5-(3-methoxy-4,5-methylenedioxybenzyl)-4,5-dihydroisoxazole-3-carboxylate

Conditions

Conditions	Yield
With triethylamine In dichloromethane at 20℃; for 24h;	69%

Raw Materials

67-64-1

4055-72-5

71186-63-5

97-53-0

22934-51-6

75-11-6

74-95-3

Downstream Products

526-34-1

Country:
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:69 Page 1 of 2 1 2 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 607-91-0

Specification

The Myristicin is an organic compound with the formula C₁₁H₁₂O₃. The IUPAC name of this chemical is 4-methoxy-6-prop-2-enyl-1,3-benzodioxole. With the CAS registry number 607-91-0, it is also named as 6-Allyl-4-methoxy-1,3-benzodioxole. The product's categories are Miscellaneous Natural Products; Aromatic Phenols. Besides, it should be stored in a closed cool and dry place.

It speculated myristicin could be metabolized to MMDA, a psychoactive drug related to MDA, in the liver. This speculation has never been confirmed and studies with the closely related compounds asarone and safrole demonstrated the proposed transamination reactions did not take place in humans. There are also data to suggest myristicin can alter the toxicity and/or metabolic pathway of some compounds and it is a weak MAOI.

Physical properties about Myristicin are: (1)ACD/LogP: 3.26; (2)ACD/LogD (pH 5.5): 3.26; (3)ACD/LogD (pH 7.4): 3.26; (4)ACD/BCF (pH 5.5): 178.18; (5)ACD/BCF (pH 7.4): 178.18; (6)ACD/KOC (pH 5.5): 1421.57; (7)ACD/KOC (pH 7.4): 1421.57; (8)#H bond acceptors: 3; (9)#Freely Rotating Bonds: 3; (10)Polar Surface Area: 27.69 Å²; (11)Index of Refraction: 1.539; (12)Molar Refractivity: 53 cm³; (13)Molar Volume: 169 cm³; (14)Polarizability: 21.01×10^-24cm³; (15)Surface Tension: 39.8 dyne/cm; (16)Density: 1.137 g/cm³; (17)Flash Point: 89.8 °C Enthalpy of; (18)Vaporization: 49.43 kJ/mol; (19)Boiling Point: 276.5 °C at 760 mmHg; (20)Vapour Pressure: 0.00805 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O1c2cc(cc(OC)c2OC1)C\C=C
(2)InChI: InChI=1/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(3)InChIKey: BNWJOHGLIBDBOB-UHFFFAOYAE
(4)Std. InChI: InChI=1S/C11H12O3/c1-3-4-8-5-9(12-2)11-10(6-8)13-7-14-11/h3,5-6H,1,4,7H2,2H3
(5)Std. InChIKey: BNWJOHGLIBDBOB-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
cat	LDLo	oral	400mg/kg (400mg/kg)	BEHAVIORAL: GENERAL ANESTHETIC LIVER: FATTY LIVER DEGERATION	American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
guinea pig	LDLo	subcutaneous	2gm/kg (2000mg/kg)	BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS LIVER: OTHER CHANGES	American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
human	TDLo	oral	5700ug/kg (5.7mg/kg)	BEHAVIORAL: WAKEFULNESS BEHAVIORAL: EUPHORIA BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"	Journal of Neuropsychiatry. Vol. 2, Pg. 205, 1961.
rabbit	LDLo	subcutaneous	900mg/kg (900mg/kg)	BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS LIVER: OTHER CHANGES	American Journal of Pharmacy Vol. 80, Pg. 563, 1909.
rat	LD50	oral	4260mg/kg (4260mg/kg)		Journal of Agricultural and Food Chemistry. Vol. 30, Pg. 563, 1982.